Retatrutide Cost in 2026: Real Prices, Dose by Week, and the Prescribed Path

You searched for what retatrutide costs, and you found chaos. Forum vials priced one way. Clinic plans priced another. No official list anywhere. Take a breath, because there is a clean way to read all of it. Retatrutide has no public retail number yet, because it is still in clinical trials. So every number you see online is either a gray-market vial or a prescribed plan. This guide sorts the two apart. It gives you real dollar ranges for weight loss care and the dose-by-week path a licensed provider follows.

One thing said plainly. Retatrutide is investigational and not FDA-approved for any use. Compounded retatrutide is not FDA-approved either, and the FDA does not review it for quality or safety. A licensed provider decides whether any treatment fits you. Results vary.

What does retatrutide cost right now?

There is no public list price for retatrutide, because it is investigational and not sold on a pharmacy shelf. Retatrutide availability is limited to clinical trials and compounded supply, which is part of why no retail number exists. Forum numbers you find online swing wildly. If your search was retatrutide price, the honest answer is still plan-specific pricing rather than a fake universal sticker. What you actually pay depends on your dose and your plan. Weight loss treatment through telehealth is priced as a plan, not a single sticker. Your weight goal shapes the plan, but not a public sticker. A prescribed retatrutide plan commonly starts around $299 a month. Branded weight loss drugs run far higher. Wegovy lists above $1,300 before insurance, and Zepbound lists above $1,000. Compounded retatrutide from clinics often lands between $200 and $500. Gray-market vials traded in forums sit near $400 to $650 for a multi-vial order, and those carry real risk. We do not stamp a fake single number on this page. You see your own price free after a short assessment, before you pay.

We will not stamp a fake number on this page to win a click. You see your own number first, before you pay.

What retatrutide is, and how a provider supervises your dose

Retatrutide is an investigational injectable made for weight loss. It is the first triple agonist to reach late-stage trials. It acts on three receptors at once: GLP-1, GIP, and glucagon. The first two quiet your appetite. The third, glucagon, nudges your metabolism to burn more energy. That triple action is the reason its weight loss numbers stand out. In the phase 2 trial published in the New England Journal of Medicine, retatrutide drove steady, dose-related weight loss (1). A licensed provider supervises every step. The provider sets your starting dose low, raises it slowly over weeks, and watches your bloodwork. You never guess your dose. That is why retatrutide is a clinical decision, not a peptide you mix from raw powder.

How much weight can you lose, and over how long?

The weight loss climbs the longer people stay on. In the phase 2 trial, the highest-dose group lost up to 24.2 percent of body weight by 48 weeks (1). Eli Lilly reported that same phase 2 weight loss result when the data was published (2). At the 24-week mark, that group had lost up to 17.5 percent of body weight (1). The placebo group lost about 2.1 percent. Lilly later reported phase 3 topline results from TRIUMPH-1: up to 28.3 percent at 80 weeks on the 12 mg dose, with a 104-week extension subgroup reaching 30.3 percent (5). The trials also showed large drops in liver fat (7). Here is the context that matters. Older weight management drugs reach lower average weight reduction than the triple agonist, though no direct trial confirms it. The people who reach the headline weight loss are the ones who stay on the plan.

Retatrutide cost dose by week

Here is the path a licensed provider follows, week by week. Your dose starts low to let your body adjust. It climbs gradually toward the target over your first weeks. The starting dose is 2 mg. The maximum in this schedule is 12 mg. Your price tracks your dose, so the early weeks generally run cheaper than the later ones. A provider keeps you on the lowest dose that controls your appetite, which is the safest plan and usually the least you will pay.

Where your price comes from on a prescribed plan

Four things move your price. Your dose comes first, because retatrutide is billed by the milligram and your dose climbs over your first weeks. Provider supervision comes second. A licensed provider sets and adjusts your dose and watches your numbers. The pharmacy comes third. A licensed US pharmacy compounds your medication, measures the dose, and labels it. Your plan comes fourth, because plans differ by how long you commit and what is bundled in. None of these is a hidden fee. The FTC's Negative Option Rule targets companies that bury fees and make cancellation hard (6). You see one clear price after the assessment, before you pay.

Get Pep'd uses licensed providers to review patients and determine whether treatment is medically appropriate. If prescribed, fulfillment follows the prescription path through a licensed US pharmacy, and you only pay if a provider prescribes.

Side effects and safety of retatrutide

Common side effects

The most common retatrutide side effects hit the gut. In the phase 2 trial, nausea, vomiting, diarrhea, and constipation were reported most often, and they ran mostly mild to moderate (1). They clustered during the early dose increases. A slow dose climb is how a provider keeps them manageable. That is the safety reason the dose starts low.

Serious risks to watch for

The serious risks are the ones honest sources name. In the phase 2 trial, investigators monitored for pancreatitis and gallbladder problems as known risks of this drug class (1). Rapid weight loss can also strip lean mass and bone, which the phase 2 investigators tracked (1). Kidney effects can follow dehydration from heavy vomiting, another reason the protocol watched fluid status (1). Unsafe online sources make every one of these risks harder to manage, because no licensed provider or pharmacy is accountable for a forum vial (3). Because retatrutide is investigational, its long-term safety data is still being gathered. That is why a licensed provider weighs the benefits against your history before you start.

How insurance and compounded options change the price

Will insurance cover retatrutide?

Insurance does not cover retatrutide today, because it is investigational with no FDA approval. Insurance plans only reimburse approved drugs for approved uses. Coverage for weight care has always been the hardest insurance fight. Even approved weight loss drugs face tight insurance rules. Many insurance plans exclude weight loss medication entirely, and others demand prior authorization. Wider availability will likely come after FDA approval, and insurance coverage may follow the same pattern as other weight loss drugs: prior authorization and a documented weight history. Until then, no insurance card lowers your price. You pay out of pocket through a prescribed plan.

Compounded and branded options

Until approval, the realistic options split in two. Compounded retatrutide is mixed by a pharmacy and is generally cheaper than a branded drug, often $200 to $500. But compounded retatrutide is not FDA-approved, and the FDA does not review it for quality (4). Branded GLP-1 weight loss drugs like Wegovy and Zepbound are FDA-approved and far more expensive, listing above $1,000 before insurance. A licensed provider helps you weigh what the medication adds for you. With insurance unlikely to help soon, your real number is the prescribed plan price you see after your assessment.

Retatrutide vs tirzepatide and semaglutide

People ask which is better for weight loss. On the trial numbers, retatrutide reaches the highest average weight loss of this group. Its phase 2 high-dose figure of up to 24.2 percent at 48 weeks (1) tops what older single-receptor and dual-receptor drugs report. Tirzepatide and semaglutide both produce real weight loss, but their average weight loss runs lower than the triple agonist. For pure fat reduction, the triple agonist looks strongest on the numbers we have. No direct trial has pitted all three against each other yet. More expensive is also not automatically better for you. If your current drug works and you feel good, switching may waste money. A provider helps you weigh the cost against what retatrutide's third hormone might add.

For the full mechanism, trial-results, dosing, and safety context behind those cost decisions, start with the retatrutide overview. If your next question is dose, use the retatrutide dosage chart. If your concern is symptoms, use the retatrutide side effects guide. If you are comparing access paths, use where to buy retatrutide online.

Where to buy retatrutide, and the safe way to do it

Search "retatrutide peptide for sale online" and you will see no-prescription research-vial listings quickly. Lab reports can be forged, product identity may be unclear, and FDA online pharmacy safety guidance tells patients to use licensed pharmacies and watch for unsafe online sources (3). A peptide forum or bulk peptide seller is not a care path. The better path is licensed provider review and licensed US pharmacy fulfillment if prescribed, with dose guidance and follow-up built into the plan.

You take a short assessment online. A provider reviews your eligibility. A licensed US pharmacy fills the prescription if a provider prescribes. You see your number before you pay anything. You are not left to interpret a raw-powder listing or guess your dose from a seller chart.

The bottom line

A provider-reviewed retatrutide plan may cost more than a research-vial listing, and that price should be evaluated against medical review, pharmacy fulfillment if prescribed, dose instructions, and follow-up. Insurance will not help until retatrutide is approved, so cost clarity matters before payment. The trial weight loss numbers are real, but they belong to people who stayed on monitored protocols. See your own number free, and decide with facts.

This content is for educational purposes and is not medical advice. Retatrutide is investigational and not FDA-approved for any use. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Trial figures cited here are average results from the named clinical trials, not a promise of individual results. A licensed provider determines whether any treatment is appropriate for you. Results vary.